Health Care's Footprint: More Than Just Emissions

The health care sector's sustainability is increasingly viewed beyond just carbon emissions. While the sector contributes significantly to global greenhouse gases, its environmental footprint also encompasses pharmaceutical waste and the growing threat of antimicrobial resistance (AMR).

India, a key global supplier of generic medicines, stands at the nexus of these evolving challenges. The country grapples with rising climate risks, an increasing burden of AMR, and the environmental accountability of its pharmaceutical industry.

Much of the environmental damage stems from improper disposal of unused or expired medicines, with little tracking. When antibiotic residues enter water systems, they foster the spread of resistant bacteria, exacerbating the AMR crisis. This environmental route is a critical, yet often underestimated, factor in combating resistance.

Furthermore, pharmaceutical supply chains, built for stable climates, are vulnerable to climate disruptions like heatwaves and floods. India's concentrated domestic supply chain faces significant risks from erratic weather patterns, highlighting the need for redundancy and preparedness.

Regulatory responses are emerging, with new guidelines for medicine disposal and state-level take-back programs like Kerala's nPROUD. Internationally, organizations like the WHO and UNEP are emphasizing wastewater management and responsible pharmaceutical disposal.

Ultimately, health care sustainability must encompass the entire lifecycle of medicines—production, distribution, use, and disposal. This integrated approach is not only crucial for environmental protection but also for the long-term competitiveness of the pharmaceutical industry.